Rare cryptic ZMYM2/FLT3 fusions that led to the activation of the FLT3 kinase were described in myeloproliferative neoplasia and adult ALL [41,42], whereas ESD coding for an esterase has not been previously described as a fusion partner. This evidence concerns the gene FLT3 and acute lymphoblastic leukemia.